MedPath
FDA Approval

valganciclovir hydrochloride

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
January 29, 2022
Labeling Type
Human Prescription Drug Label
Valganciclovir(50 mg in 1 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

MSN Pharmaceuticals Inc.

Novadoz Pharmaceuticals LLC

079229051

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

valganciclovir hydrochloride

Product Details

NDC Product Code
72205-019
Application Number
ANDA210169
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
September 14, 2022
POVIDONE K30Inactive
Code: U725QWY32XClass: IACT
Code: 4P3T9QF9NZClass: ACTIRQuantity: 50 mg in 1 mL
FUMARIC ACIDInactive
Code: 88XHZ13131Class: IACT
MANNITOLInactive
Code: 3OWL53L36AClass: IACT
SACCHARIN SODIUMInactive
Code: SB8ZUX40TYClass: IACT
SODIUM BENZOATEInactive
Code: OJ245FE5EUClass: IACT
© Copyright 2025. All Rights Reserved by MedPath